| |
|
|
|
|
|
|
|
|
2003 |
|
|
|
| Publication | Author Affiliation | Website
| PDF | | Gullbo J, Wallinder C, Tullberg M, Lövborg H, Ehrsson H, Lewensohn R, Nygren P, Luthman K, and Larsson R. (2003) Antitumor activity of the novel melphalan containing tripeptide J3 (L-prolyl-L-melphalanyl-p-L-fluorophenylalanine ethyl ester): Comparison with its m-L-sarcolysin analogue P2. Mol. Cancer Ther. 2: 1331. | Uppsala University | Link | | | Dahl JP, Wang-Dunlop J, Gonzales C, Goad MEP, Mark RJ, and Kwak SP. (2003) Characterization of the WAVE1 Knock-Out Mouse: Implications for CNS Development. J. Neurosci., 23: 3343. | Wyeth Research | Link | | | Minguez, JM, SY Kim, KA Giuliano, R Balachandran, C Madiraju, BW Day, and DP Curran. (2003) Synthesis and biological assessment of simplified analogues of the potent microtubule stabilizer (+)-discodermolide. Bioorg Med Chem. 11:3335-57. | University of Pittsburgh | | | | Vogt, A, KA Cooley, M Brisson, MG Tarpley, P Wipf, and JS Lazo. (2003) Cell-active dual specificity phosphatase inhibitors identified by high-content screening. Chem Biol. 10:733-42. | University of Pittsburgh | | | | Kawamura, YI, R Kawashima, Y Shirai, R Kato, T Hamabata, M Yamamoto, K Furukawa, K Fujihashi, JR McGhee, H Hayashi, T Dohi. (2003) Cholera toxin activates dendritic cells through dependence on GM1-ganglioside which is mediated by NF-kB translocation. Eur. J. Immunol. 33:3205-3212 | International Medical Center of Japan, Tokyo | | | | Li Z, Y Yan, EA Powers, X Ying, K Janjua, T Garyantes, B Baron. (2003) Identification of gap junction blockers using automated fluorescence microscopy imaging. J Biomol Screen 8:489-499 | Aventis | | | | Giuliano, KA, JR Haskins and DL Taylor. (2003) Advances in high content screening for drug discovery. Assay and Drug Development Technologies. 1:565-577 | Cellomics, Inc. | | | | Giuliano KA. (2003) High-content profiling of drug-drug interactions: cellular targets involved in the modulation of microtubule drug action by the antifungal ketoconazole. J Biomol Screen 8:125-35 | Cellomics, Inc. | | |
Back to top
|
|
|
|
|
|
|
|
|
|
Home 
HCS Library 
top